Abeona Therapeutics Inc.
ABEO
$3.06
-$0.03-0.97%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
6/1/2023
-
Globe Newswire
5/29/2023
-
Zolmax
5/28/2023
-
Ticker Report
5/24/2023
-
SeekingAlpha
5/24/2023
-
SeekingAlpha
5/23/2023
-
SeekingAlpha.com: All News
5/22/2023
-
Globe Newswire
5/16/2023
-
Globe Newswire
5/16/2023
-
Ticker Report
5/16/2023
-
Zolmax
Abeona Therapeutics First Quarter 2023 Earnings: US$0.54 loss per share (vs US$3.59 loss in 1Q 2022)
5/13/2023
-
Simply Wall St
5/11/2023
-
SeekingAlpha.com: All News
5/11/2023
-
Benzinga
5/11/2023
-
Globe Newswire
5/11/2023
-
Globe Newswire
4/30/2023
-
Ticker Report
4/21/2023
-
Zolmax
4/21/2023
-
Ticker Report
4/20/2023
-
Ticker Report
4/10/2023
-
Globe Newswire
3/31/2023
-
Ticker Report
3/29/2023
-
Globe Newswire
3/24/2023
-
Globe Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 11, 2023
Period Date
Friday, March 31, 2023
Next Filing
Week of Aug 7 and 11 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
646 813 4701
Address
1330 Avenue of the Americas
New York, NY 10019
New York, NY 10019
Country
Year Founded
--
Business Description
Sector
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous...
more
